About Complete Genomics
Complete Genomics is a company based in San Jose (United States) founded in 2006 by Radoje Drmanac was acquired by Swiss Rockets in February 2026. Complete Genomics has raised $124.99 million across 4 funding rounds from investors including Huada Gene, Orbimed and Swiss Rockets. Complete Genomics offers products and services including DNBSEQ™ Technology, Kits & Reagents, and Sequencing Platforms. Complete Genomics operates in a competitive market with competitors including Nanopore, Cepheid, PacBio, Omniome and QuantuMDx, among others.
- Headquarter San Jose, United States
- Founders Radoje Drmanac
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Complete Genomics Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$124.99 M (USD)
in 4 rounds
-
Latest Funding Round
$39 M (USD), Series E
Aug 19, 2010
-
Investors
Huada Gene
& 8 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Complete Genomics
Complete Genomics offers a comprehensive portfolio of products and services, including DNBSEQ™ Technology, Kits & Reagents, and Sequencing Platforms.
Delivers accurate PCR-free NGS for genomics research applications.
Facilitates sample extraction and library preparation for sequencing.
Provides fast data for WGS and spatial omics analysis.
Funding Insights of Complete Genomics
Complete Genomics has successfully raised a total of $124.99M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $39 million completed in August 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Complete Genomics
Complete Genomics has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Huada Gene, Orbimed and Swiss Rockets.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in US life sciences and healthtech firms.
|
Locked | Locked | Locked | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
Venture capital investment and entrepreneur support services.
|
Locked | Locked | Locked |
Investor details for Complete Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Complete Genomics
Investment portfolio details for Complete Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Complete Genomics
Detailed financials for Complete Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Complete Genomics Comparisons
Peer comparison for Complete Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Complete Genomics
Complete Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, Cepheid, PacBio, Omniome and QuantuMDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
Detailed competitors of Complete Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Complete Genomics
Complete news archive for Complete Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Complete Genomics
Complete Genomics was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Complete Genomics is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Complete Genomics is a funded company, having raised a total of $124.99M across 4 funding rounds to date.
Complete Genomics was founded in 2006 in San Jose, United States, within the biotechnology sector focused on genomics. A proprietary DNA nanoball sequencing technology is utilized to create the Revolocity Platform, which supports whole genome and exome sequencing with fragment lengths of 250-500 bp. Analysis algorithms and data management software are provided for variant reports and assemblies, enabling research operations in human DNA sequencing.
Complete Genomics offers DNBSEQ™ Technology, Kits & Reagents, and Sequencing Platforms.
Complete Genomics has 9 investors. Key investors include Huada Gene, Orbimed, Swiss Rockets, Prospect Venture Partners, and Highland Capital Partners.